| Brand Name | COCHLEAR¿ VISTAFIX® VXA300 ABUTMENT 6MM |
| Common Device Name | COCHLEAR BAHA VISTAFIX SYSTEM |
| Manufacturer (Section D) |
| COCHLEAR BONE ANCHORED SOLUTIONS AB |
| konstruktionsvägen 14 |
| mölnlycke, 435 3 3 |
| SW 435 33 |
|
| Manufacturer (Section G) |
| COCHLEAR BONE ANCHORED SOLUTIONS AB |
| konstruktionsvägen 14 |
|
| mölnlycke, 435 3 3 |
|
SW
435 33
|
|
| Manufacturer Contact |
|
yaneesa
vetsandonphong
|
| unit ug-1, vertical podium |
| no.8 jalan kerinchi, |
| kuala lumpur, wilayah persekutuan 59200
|
|
MY
59200
|
|
| MDR Report Key | 14785995 |
| Report Number | 6000034-2022-01884 |
| Device Sequence Number | 12215527 |
| Product Code |
FZE
|
| UDI-Device Identifier | 09321502021685 |
| UDI-Public | (01)09321502021685(10)175114(17)230305 |
| Combination Product (Y/N) | N |
| Initial Reporter State | TX |
| Initial Reporter Country | US |
| PMA/510(K) Number | K945154 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Implanted Year | 2019 |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Health Professional |
| Initial Reporter Occupation |
Other
|
| Type of Report
| Initial |
| Report Date (Section B) |
06/03/2022 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Lay User/Patient
|
| Device Expiration Date | 03/05/2023 |
| Device Model Number | 92996 |
| Device Catalogue Number | 92996 |
| Device Lot Number | 175114 |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Initial |
| Initial Date Received by Manufacturer | 06/03/2022 |
| Initial Report FDA Received Date | 06/23/2022 |
| Was Device Evaluated by Manufacturer? (Y/N) |
Device Not Returned to Manufacturer
|
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 14 YR |
| Patient Sex | Female |